These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34844535)

  • 21. Enhanced Antitumor Activity of Monophosphate Ester Prodrugs of Gemcitabine: In Vitro and In Vivo Evaluation.
    Qi H; Lu J; Li J; Wang M; Xu Y; Wang Y; Zhang H
    J Pharm Sci; 2016 Sep; 105(9):2966-2973. PubMed ID: 26994559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and properties of novel L-isonucleoside modified oligonucleotides and siRNAs.
    Zhang J; Chen Y; Huang Y; Jin HW; Qiao RP; Xing L; Zhang LR; Yang ZJ; Zhang LH
    Org Biomol Chem; 2012 Oct; 10(37):7566-77. PubMed ID: 22895883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aryloxy Pivaloyloxymethyl Prodrugs as Nucleoside Monophosphate Prodrugs.
    Alanazi AS; Miccoli A; Mehellou Y
    J Med Chem; 2021 Nov; 64(22):16703-16710. PubMed ID: 34734726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming the delivery barrier of oligonucleotide drugs and enhancing nucleoside drug efficiency: The use of nucleolipids.
    Zhou X; Wang S; Zhu Y; Pan Y; Zhang L; Yang Z
    Med Res Rev; 2020 Jul; 40(4):1178-1199. PubMed ID: 31820472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of phosphoramidate prodrugs: ProTide approach.
    Serpi M; Madela K; Pertusati F; Slusarczyk M
    Curr Protoc Nucleic Acid Chem; 2013 Jun; Chapter 15():15.5.1-15.5.15. PubMed ID: 23775807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation of nucleoside-carbohydrate phosphodiester prodrug analogues by chemoenzymatic procedure.
    Rodríguez-Pérez T; Fernández S; Sanghvi YS; Gotor V; Ferrero M
    Nucleic Acids Symp Ser (Oxf); 2008; (52):101-2. PubMed ID: 18776273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Floxuridine Oligonucleotide Conjugates Carrying Potential Enhancers of Cellular Uptake.
    Aviñó A; Clua A; Bleda MJ; Eritja R; Fàbrega C
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of Nucleosides and Nucleotides Prodrugs.
    De Schutter C; Ehteshami M; Hammond ET; Amblard F; Schinazi RF
    Curr Pharm Des; 2017 Oct; ():. PubMed ID: 29022511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Base-Modified Nucleosides as Chemotherapeutic Agents: Past and Future.
    Burke MP; Borland KM; Litosh VA
    Curr Top Med Chem; 2016; 16(11):1231-41. PubMed ID: 26369814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress in the development of anti-hepatitis C virus nucleoside and nucleotide prodrugs.
    Madela K; McGuigan C
    Future Med Chem; 2012 Apr; 4(5):625-50. PubMed ID: 22458682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acyclic nucleosides as antiviral compounds.
    Freeman S; Gardiner JM
    Mol Biotechnol; 1996 Apr; 5(2):125-37. PubMed ID: 8734425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New antiviral nucleoside prodrugs await application.
    Anastasi C; Quéléver G; Burlet S; Garino C; Souard F; Kraus JL
    Curr Med Chem; 2003 Sep; 10(18):1825-43. PubMed ID: 12871107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dipeptide monoester prodrugs of floxuridine and gemcitabine-feasibility of orally administrable nucleoside analogs.
    Tsume Y; Borras Bermejo B; Amidon GL
    Pharmaceuticals (Basel); 2014 Jan; 7(2):169-91. PubMed ID: 24473270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. γ-Non-Symmetrically Dimasked TriPPPro Prodrugs as Potential Antiviral Agents against HIV.
    Zhao C; Jia X; Schols D; Balzarini J; Meier C
    ChemMedChem; 2021 Feb; 16(3):499-512. PubMed ID: 33089929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleotide prodrugs for HCV therapy.
    Sofia MJ
    Antivir Chem Chemother; 2011 Aug; 22(1):23-49. PubMed ID: 21860070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prodrug-type antisense oligonucleotides with enhanced nuclease stability and anti-tumour effects.
    Ren H; Zhang Z; Zhang W; Feng X; Xu L
    Eur J Pharm Sci; 2021 Jul; 162():105832. PubMed ID: 33826934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acid-Triggered Release of Native Gemcitabine Conjugated in Polyketal Nanoparticles for Enhanced Anticancer Therapy.
    Zhong H; Mu J; Du Y; Xu Z; Xu Y; Yu N; Zhang S; Guo S
    Biomacromolecules; 2020 Feb; 21(2):803-814. PubMed ID: 31995366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane-permeable Triphosphate Prodrugs of Nucleoside Analogues.
    Gollnest T; Dinis de Oliveira T; Rath A; Hauber I; Schols D; Balzarini J; Meier C
    Angew Chem Int Ed Engl; 2016 Apr; 55(17):5255-8. PubMed ID: 27008042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nucleoside boranephosphonates as potential therapeutic agents].
    Filipiak E; Gołębiewska J
    Postepy Biochem; 2022 Jun; 68(2):142-148. PubMed ID: 35792645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleoside and nucleobase analogs in cancer treatment: not only sapacitabine, but also gemcitabine.
    Muggia F; Diaz I; Peters GJ
    Expert Opin Investig Drugs; 2012 Apr; 21(4):403-8. PubMed ID: 22404148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.